---
figid: PMC9267440__jcm-11-03622-g001
figtitle: 'Identification of Genetic Variations in the NAD-Related Pathways for Patients
  with Major Depressive Disorder: A Case-Control Study in Taiwan'
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC9267440
filename: jcm-11-03622-g001.jpg
figlink: /pmc/articles/PMC9267440/figure/jcm-11-03622-f001/
number: F1
caption: 'Brief summary of NAD+ biosynthesis pathways. NAD+ biosynthesis includes
  the de novo pathway (starts from dietary tryptophan) and nicotinate metabolism (Preiss-Handler
  pathway in blue and Salvage pathway in green, starts from niacin). Niacin includes
  nicotinamide, nicotinic acid, and nicotinamide riboside. Dietary tryptophan can
  be converted to either NAD+ or acetyl-CoA via the kynurenine metabolic pathway in
  mammals. ACMSD is the key enzyme that can moderate NAD+ homeostasis. Abbreviations:
  ACMSD, ACMS decarboxylase; AFMID, N-formylkynurenine formamidase; ALDH8A1, 2-aminomuconic
  semialdehyde dehydrogenase; CoA, coenzyme A; HAAO, 3-hydroxyanthranilate 3,4-dioxygenase;
  IDO, indoleamine 2,3-dioxygenase; KMO, kynurenine 3-monooxygenase; KYNU, kynureninase;
  NAD+, nicotinamide adenine dinucleotide; NAMPT, nicotinamide phosphoribosyltransferase;
  NAPRT, nicotinic acid phosphoribosyltransferase; NMNAT, nicotinamide mononucleotide
  adenylyltransferase; NRK, nicotinamide riboside kinase; QPRT, quinolinate phosphoribosyl
  transferase; TCA cycle, tricarboxylic acid cycle; TDO, tryptophan 2,3-dioxygenase.'
papertitle: 'Identification of Genetic Variations in the NAD-Related Pathways for
  Patients with Major Depressive Disorder: A Case-Control Study in Taiwan.'
reftext: Daniel Tzu-Li Chen, et al. J Clin Med. 2022 Jul;11(13):3622.
year: '2022'
doi: 10.3390/jcm11133622
journal_title: Journal of Clinical Medicine
journal_nlm_ta: J Clin Med
publisher_name: MDPI
keywords: kynurenine pathway (KP) | major depressive disorder (MDD) | nicotinamide
  adenine dinucleotide (NAD) | single nuclear polymorphism (SNPs)
automl_pathway: 0.9498345
figid_alias: PMC9267440__F1
figtype: Figure
redirect_from: /figures/PMC9267440__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9267440__jcm-11-03622-g001.html
  '@type': Dataset
  description: 'Brief summary of NAD+ biosynthesis pathways. NAD+ biosynthesis includes
    the de novo pathway (starts from dietary tryptophan) and nicotinate metabolism
    (Preiss-Handler pathway in blue and Salvage pathway in green, starts from niacin).
    Niacin includes nicotinamide, nicotinic acid, and nicotinamide riboside. Dietary
    tryptophan can be converted to either NAD+ or acetyl-CoA via the kynurenine metabolic
    pathway in mammals. ACMSD is the key enzyme that can moderate NAD+ homeostasis.
    Abbreviations: ACMSD, ACMS decarboxylase; AFMID, N-formylkynurenine formamidase;
    ALDH8A1, 2-aminomuconic semialdehyde dehydrogenase; CoA, coenzyme A; HAAO, 3-hydroxyanthranilate
    3,4-dioxygenase; IDO, indoleamine 2,3-dioxygenase; KMO, kynurenine 3-monooxygenase;
    KYNU, kynureninase; NAD+, nicotinamide adenine dinucleotide; NAMPT, nicotinamide
    phosphoribosyltransferase; NAPRT, nicotinic acid phosphoribosyltransferase; NMNAT,
    nicotinamide mononucleotide adenylyltransferase; NRK, nicotinamide riboside kinase;
    QPRT, quinolinate phosphoribosyl transferase; TCA cycle, tricarboxylic acid cycle;
    TDO, tryptophan 2,3-dioxygenase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Acmsd
  - Mat1a
  - Aldh8a1
  - Hps3
  - Gnat2
  - Ido1
  - Tdo2
  - Afmid
  - Kmo
  - Kynu
  - Haao
  - Qprt
  - Naprt
  - Nmnat1
  - Nrk
  - Nampt
  - ACMSD
  - TWIST2
  - ALDH8A1
  - IDO1
  - DLX3
  - TDO2
  - AFMID
  - KMO
  - KYNU
  - HAAO
  - ATP8A2
  - QPRT
  - NAPRT
  - NMNAT1
  - NRK
  - NAMPT
  - acmsd
  - aldh8a1
  - napbb
  - ido1
  - afmid
  - kmo
  - kynu
  - haao
  - naprt
  - si:zfos-2326c3.2
---
